亚裔与非亚裔非鼻咽头颈癌患者的结局差异
该研究基于加拿大不列颠哥伦比亚省2001至2010年诊断为非鼻咽头颈鳞状细胞癌的3036例患者,采用Kaplan-Meier法和Cox回归分析种族与总生存的关系。结果显示亚裔患者虽具有更差预后特征且接受多模式治疗更少,但多因素分析中总生存优于非亚裔,5年总生存差异显著。
要点
- 亚裔患者ECOG状态更差(29% vs 23%,P=0.07)、肿瘤更大(33% vs 21%,P=0.02)且口腔癌比例更高(38% vs 25%,P<0.001)。
- 亚裔接受多模式治疗的比例低于非亚裔(90% vs 95%,P=0.02)。
- 多因素分析中亚裔总生存优于非亚裔(HR=0.50,95%CI 0.25-0.99,P=0.05)。
核心结论
- 尽管具有多项更差预后特征且治疗强度较低,亚裔患者的总生存仍倾向于优于非亚裔患者。
研究设计与样本
- 基于人群的回顾性研究,纳入2001至2010年加拿大不列颠哥伦比亚省诊断为非鼻咽头颈鳞状细胞癌的患者共3036例,中位年龄64岁,74%为男性,7%为亚裔。
主要发现
- 亚裔患者ECOG状态更差(29% vs 23%,P=0.07)、肿瘤更大(33% vs 21%,P=0.02)、口腔癌比例更高(38% vs 25%,P<0.001)。
- 亚裔接受多模式治疗的比例低于非亚裔(90% vs 95%,P=0.02),但从不吸烟比例更高(49% vs 15%,P<0.001)且已婚或有伴侣比例更高(80% vs 69%,P=0.02)。
- 多因素模型显示亚裔总生存优于非亚裔(HR=0.50,95%CI 0.25-0.99,P=0.05)。
- 3年总生存亚裔与非亚裔无显著差异(41% vs 42%,P=0.18),5年总生存差异显著(22% vs 19%,P=0.03)。
- 按治疗方式分层,仅单纯放疗组亚裔总生存显著更优(HR=0.71,95%CI 0.51-0.99,P=0.04),其余组两组结局相当。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: To evaluate disparities in overall survival (OS) between Asian and non-Asian patients diagnosed with non-nasopharyngeal head and neck cancer (HNC). STUDY DESIGN: This was a population-based, retrospective study of patients diagnosed with non-nasopharyngeal HNC of squamous cell carcinoma histology between 2001 and 2010 in British Columbia, Canada. METHODS: Using Kaplan-Meier methods and Cox regression models, we examined the relationship between race and OS. RESULTS: A total of 3,036 patients were included in the study. Median age was 64 years, 74% were men, and 7% were Asians. Asians had worse Eastern Cooperative Oncology Group (ECOG) status (29% vs. 23%, P = .07) and larger tumors (33% vs. 21%, P = .02), and were more likely to be diagnosed with oral cavity cancers (38% vs. 25%, P < .001) than non-Asians. Asians were also less likely to receive multimodality therapy than non-Asians (90% vs. 95%, P = .02). Asians were more likely to have never smoked (49% vs. 15%, P < .001) and to be married or with a partner (80% vs. 69%, P = .02). Multivariate models showed that Asians had better OS than non-Asians (hazard ratio [HR] = 0.50, 95% confidence interval [CI] = 0.25-0.99, P = .05). Three-year OS did not differ significantly between Asians and non-Asians (41% vs. 42%, P = .18); however, 5-year OS did (22% vs. 19% P = .03). Stratifying by treatment type, outcomes were comparable in both groups except for radiotherapy alone, where Asians showed significantly better OS (HR = 0.71, 95% CI = 0.51-0.99, P = .04). Advanced age, worse ECOG, greater tumor size, and lack of treatment also correlated with inferior OS. CONCLUSIONS: Despite several worse prognostic features and less aggressive treatment, Asians tended to exhibit better OS than non-Asians. LEVEL OF EVIDENCE: 2c. Laryngoscope, 127:2528-2533, 2017.
引用
- Kim JD, Chang JT, Moghaddamjou A, et al. Asian and non-Asian disparities in outcomes of non-nasopharyngeal head and neck cancer. Laryngoscope. 2017. PMID: 28397269. doi:10.1002/lary.26603
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。